<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02278601</url>
  </required_header>
  <id_info>
    <org_study_id>CTGL13feb013</org_study_id>
    <nct_id>NCT02278601</nct_id>
  </id_info>
  <brief_title>Comparison of Regimens VAMB, CIPCEA, PCEA</brief_title>
  <acronym>COLEUS</acronym>
  <official_title>Comparison of Variable-frequency Automated Mandatory Bolus (VAMB), Computer-integrated Patient Controlled Epidural Analgesia (CIPCEA) and Conventional Patient Controlled Epidural Analgesia (PCEA) During Labour</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KK Women's and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KK Women's and Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidural analgesia is the gold standard of pain relief for labour pain. Despite this, more
      than 50% of parturients continue to experience pain leading to suffering and increased
      caregiver workload. Women who have increased pain tend to have lower successful patient bolus
      demands when patient controlled epidural analgesia (PCEA) is utilised and have dysfunctional
      labour requiring obstetric intervention such as Caesarean or instrumental delivery. Labour
      pain often escalates and worsens as labour progresses requiring an individualized, variable,
      flexible analgesic regimen. Bolus epidural administrations have been shown to improve uniform
      spread of local anaesthetics with better pain relief, compared to fixed background infusions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our research team developed two novel epidural delivery regimens: computer-integrated PCEA
      (CIPCEA) (variable flexible background infusion) and variable-frequency automated mandatory
      bolus (VAMB) focused on individualization of analgesic requirements. This phase 3
      double-blinded randomized controlled trial will compare the two novel regimens, and each with
      conventional PCEA, in reducing breakthrough pain (failure of the regimen to provide adequate
      pain relief, necessitating unscheduled epidural supplementation) incidence as the primary
      outcome in nulliparous term women requesting labour epidural analgesia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with Breakthrough pain</measure>
    <time_frame>1 day</time_frame>
    <description>Unscheduled epidural supplementation by anaesthetist due to pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with Caesarean section</measure>
    <time_frame>1 day</time_frame>
    <description>Number of subjects with Caesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with Instrumental delivery</measure>
    <time_frame>1 day</time_frame>
    <description>Number of subjects with Instrumental delivery (forceps, vacuum delivery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foetal outcome</measure>
    <time_frame>1 day</time_frame>
    <description>APGAR scores</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">3412</enrollment>
  <condition>Breakthrough Pain</condition>
  <arm_group>
    <arm_group_label>VAMB variable automated</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>variable frequency automated mandatory bolus (VAMB) up-down frequency of 5mls ropivacaine/fentanyl solution in bolus with epidural delivery system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CIPCEA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>computer integrated patient controlled epidural analgesia (CIPCEA) up-down variable basal infusion of ropivacaine/fentanyl solution with epidural delivery system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patient controlled epidural analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient controlled epidural analgesia (PCEA) with fixed basal infusion of ropivacaine/fentanyl solution with epidural delivery system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>epidural delivery system</intervention_name>
    <description>epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution</description>
    <arm_group_label>VAMB variable automated</arm_group_label>
    <arm_group_label>CIPCEA</arm_group_label>
    <arm_group_label>patient controlled epidural analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution</description>
    <arm_group_label>VAMB variable automated</arm_group_label>
    <arm_group_label>CIPCEA</arm_group_label>
    <arm_group_label>patient controlled epidural analgesia</arm_group_label>
    <other_name>amide local anaesthetic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>epidural delivery system for maintenance of labour epidural analgesia using 0.1% ropivacaine (amide local anaesthetic) with 2mcg/ml fentanyl (opioid) as maintenance solution</description>
    <arm_group_label>VAMB variable automated</arm_group_label>
    <arm_group_label>CIPCEA</arm_group_label>
    <arm_group_label>patient controlled epidural analgesia</arm_group_label>
    <other_name>opioid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy (ASA physical status 1 and 2) nulliparous parturients at term (≥36 weeks
             gestation);

          2. Singleton foetus

          3. Early labour (cervical dilation ≤5cm)

          4. Request labour epidural analgesia

          5. At least 21 years of age

        Exclusion Criteria:

          1. parturients with multiple pregnancies

          2. non-cephalic foetal presentation

          3. obstetric (e.g. pre-eclampsia, premature rupture of amniotic membranes, gestational
             diabetes on insulin) and uncontrolled medical (e.g. cardiac disease) complications

          4. have contraindications to neuraxial blockade or have received parenteral opioids with
             the last 2 hours.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ban L Sng, FANZCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>KK Women's and Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ban L Sng, FANZCA</last_name>
    <phone>+6563941081</phone>
    <email>sng.ban.leong@kkh.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alex T Sia, MMED+</last_name>
    <phone>+6563941081</phone>
    <email>Alex.Sia.TH@kkh.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KK Women's and Children's Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>229899</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ban L Sng, FANZCA</last_name>
      <phone>+6563941081</phone>
      <email>sng.ban.leong@kkh.com.sg</email>
    </contact>
    <contact_backup>
      <last_name>Alex T Sia, MD</last_name>
      <phone>+6563941081</phone>
      <email>alex.sia.th@kkh.com.sg</email>
    </contact_backup>
    <investigator>
      <last_name>Ban L Sng, FANZCA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2014</study_first_submitted>
  <study_first_submitted_qc>October 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2014</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breakthrough pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breakthrough Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

